Approval · Notice of Compliance 23094 · 2019
GALLI EO: Notice of Compliance 23094
Issued November 13, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23094
- Date
- November 13, 2019
- Company
- Ire Elit S.A.Fleurus, --, Belgium
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GALLI EO | 02492806 | Marketed |
Medicinal ingredients
- GALLIUM (68GA) CHLORIDE 1 GBQ per ML